» Articles » PMID: 23601326

Accumulation of Exogenous Activated TGF-β in the Superficial Zone of Articular Cartilage

Overview
Journal Biophys J
Publisher Cell Press
Specialty Biophysics
Date 2013 Apr 23
PMID 23601326
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

It was recently demonstrated that mechanical shearing of synovial fluid (SF), induced during joint motion, rapidly activates latent transforming growth factor β (TGF-β). This discovery raised the possibility of a physiological process consisting of latent TGF-β supply to SF, activation via shearing, and transport of TGF-β into the cartilage matrix. Therefore, the two primary objectives of this investigation were to characterize the secretion rate of latent TGF-β into SF, and the transport of active TGF-β across the articular surface and into the cartilage layer. Experiments on tissue explants demonstrate that high levels of latent TGF-β1 are secreted from both the synovium and all three articular cartilage zones (superficial, middle, and deep), suggesting that these tissues are capable of continuously replenishing latent TGF-β to SF. Furthermore, upon exposure of cartilage to active TGF-β1, the peptide accumulates in the superficial zone (SZ) due to the presence of an overwhelming concentration of nonspecific TGF-β binding sites in the extracellular matrix. Although this response leads to high levels of active TGF-β in the SZ, the active peptide is unable to penetrate deeper into the middle and deep zones of cartilage. These results provide strong evidence for a sequential physiologic mechanism through which SZ chondrocytes gain access to active TGF-β: the synovium and articular cartilage secrete latent TGF-β into the SF and, upon activation, TGF-β transports back into the cartilage layer, binding exclusively to the SZ.

Citing Articles

Extracecellulr vesicles (EVs) microRNAs (miRNAs) derived from mesenchymal stem cells (MSCs) in osteoarthritis (OA); detailed role in pathogenesis and possible therapeutics.

Pakdaman Kolour S, Nematollahi S, Dehbozorgi M, Fattahi F, Movahed F, Esfandiari N Heliyon. 2025; 11(3):e42258.

PMID: 40007782 PMC: 11850152. DOI: 10.1016/j.heliyon.2025.e42258.


Vascular Smooth Muscle Cells Transdifferentiate into Chondrocyte-Like Cells and Facilitate Meniscal Fibrocartilage Regeneration.

Yan W, Cheng J, Wu H, Gao Z, Li Z, Cao C Research (Wash D C). 2024; 7:0555.

PMID: 39717465 PMC: 11665451. DOI: 10.34133/research.0555.


Cell mediated reactions create TGF-β delivery limitations in engineered cartilage.

Dogru S, Alba G, Pierce K, Wang T, Kia D, Albro M Acta Biomater. 2024; 190:178-190.

PMID: 39447669 PMC: 11614674. DOI: 10.1016/j.actbio.2024.10.032.


Advances in regenerative rehabilitation in the rehabilitation of musculoskeletal injuries.

Zhang Z, Yao P, Fan S Regen Med. 2024; 19(6):345-354.

PMID: 38860852 PMC: 11346529. DOI: 10.1080/17460751.2024.2357956.


Growth factors that drive aggrecan synthesis in healthy articular cartilage. Role for transforming growth factor-β?.

van der Kraan P, van Caam A, Blaney Davidson E, van den Bosch M, van de Loo F Osteoarthr Cartil Open. 2024; 6(2):100459.

PMID: 38486843 PMC: 10938168. DOI: 10.1016/j.ocarto.2024.100459.


References
1.
Lafeber F, Vander Kraan P, Huber-Bruning O, Vanden Berg W, Bijlsma J . Osteoarthritic human cartilage is more sensitive to transforming growth factor beta than is normal cartilage. Br J Rheumatol. 1993; 32(4):281-6. DOI: 10.1093/rheumatology/32.4.281. View

2.
Shi S, Mercer S, Eckert G, Trippel S . Growth factor regulation of growth factors in articular chondrocytes. J Biol Chem. 2009; 284(11):6697-704. PMC: 2652312. DOI: 10.1074/jbc.M807859200. View

3.
Haudenschild D, Hong E, Yik J, Chromy B, Morgelin M, Snow K . Enhanced activity of transforming growth factor β1 (TGF-β1) bound to cartilage oligomeric matrix protein. J Biol Chem. 2011; 286(50):43250-8. PMC: 3234822. DOI: 10.1074/jbc.M111.234716. View

4.
Hildebrand A, Romaris M, Rasmussen L, Heinegard D, Twardzik D, Border W . Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor beta. Biochem J. 1994; 302 ( Pt 2):527-34. PMC: 1137259. DOI: 10.1042/bj3020527. View

5.
Studer R, Georgescu H, Miller L, Evans C . Inhibition of transforming growth factor beta production by nitric oxide-treated chondrocytes: implications for matrix synthesis. Arthritis Rheum. 1999; 42(2):248-57. DOI: 10.1002/1529-0131(199902)42:2<248::AID-ANR6>3.0.CO;2-S. View